See Photo report
Attention, non CNRS staff
© Christophe HARGOUES / IGMM / CNRS Images
Pipetting a dilution of the molecule ABX464 used to inhibit HIV (human immunodeficiency virus). This dilution is then deposited on cells from patients infected with HIV. The aim is to determine the effectiveness, in patients with chronic HIV, of the ABX464 molecule, a drug candidate that can reduce virus reservoirs. This photograph was taken in the CNRS-ABIVAX cooperative laboratory attached to the Institute of Molecular Genetics of Montpellier (IGMM).